Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment (TA) Analyses Supporting Lefamulin Dose Selection for the Treatment of Patients With Community-Acquired Bacterial Pneumonia (CABP)
2019 ◽
Vol 74
(Supplement_3)
◽
pp. iii35-iii41
◽
2017 ◽
Vol 4
(suppl_1)
◽
pp. S530-S530
◽
Keyword(s):
2018 ◽
Vol 45
(4)
◽
pp. 523-535
◽
Keyword(s):
1995 ◽
Vol 21
(3)
◽
pp. 418-421
◽
2006 ◽
Vol 40
(7)
◽
pp. 587-591
◽
Keyword(s):